Invesco Ltd. Syndax Pharmaceuticals Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 50,640 shares of SNDX stock, worth $717,568. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,640

Previous 50,061 1.16%

Holding current value

$717,568

Previous $1.03 Million 5.16%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$17.93 - $24.81 $10,381 - $14,364	579 Added 1.16%	50,640 $974,000
Q2 2024 Aug 13, 2024	BUY	$18.82 - $23.79 $23,073 - $29,166	1,226 Added 2.51%	50,061 $1.03 Million
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $384,640 - $479,483	19,515 Added 66.56%	48,835 $1.16 Million
Q4 2023 Feb 12, 2024	SELL	$11.39 - $21.67 $82,269 - $156,522	-7,223 Reduced 19.77%	29,320 $633,000
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $88,499 - $132,688	6,095 Added 20.02%	36,543 $530,000
Q2 2023 Aug 11, 2023	SELL	$19.35 - $22.31 $3.48 Million - $4.01 Million	-179,705 Reduced 85.51%	30,448 $637,000
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $3.93 Million - $5.51 Million	190,006 Added 943.1%	210,153 $4.44 Million
Q4 2022 Feb 13, 2023	SELL	$20.64 - $26.24 $1.16 Million - $1.48 Million	-56,244 Reduced 73.63%	20,147 $512,000
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $996,874 - $1.34 Million	53,856 Added 238.99%	76,391 $1.84 Million
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $65,185 - $93,094	4,779 Added 26.91%	22,535 $434,000
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $2,196 - $3,278	148 Added 0.84%	17,756 $308,000
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $36,323 - $53,590	-2,385 Reduced 11.93%	17,608 $386,000
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $31,568 - $45,064	2,276 Added 12.85%	19,993 $383,000
Q2 2021 Aug 17, 2021	BUY	$13.42 - $25.18 $108,285 - $203,177	8,069 Added 83.63%	17,717 $305,000
Q1 2021 May 17, 2021	SELL	$19.28 - $24.59 $5.84 Million - $7.45 Million	-302,815 Reduced 96.91%	9,648 $216,000
Q4 2020 Feb 16, 2021	BUY	$15.1 - $26.44 $3.73 Million - $6.53 Million	247,025 Added 377.49%	312,463 $6.95 Million
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $876,214 - $1.14 Million	65,438 New	65,438 $966,000
Q2 2020 Aug 14, 2020	SELL	$8.94 - $20.98 $537,758 - $1.26 Million	-60,152 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $400,010 - $723,628	60,152 New	60,152 $660,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

89.9M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $802M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account